Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000315066-17-002191
Filing Date
2017-03-02
Accepted
2017-03-02 16:14:39
Documents
1
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7991
  Complete submission text file 0000315066-17-002191.txt   9646
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Reporting) CIK: 0000315066 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37695 | Film No.: 17658931

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations